Christoph Lengauer
InvestorCSO at Curie.Bio · Board director at Hookipa Pharma
Boston, Massachusetts, United States
About
Christoph Lengauer is the co-founder and Chief Scientific Officer of Curie.Bio, where he supports founders launching therapeutics companies. His work combines drug development expertise, services, and seed capital to help move companies from initial concept through Series A financing.
Contact· published on Christoph's own website
Board director at Hookipa Pharma
Intro paths
→
In turn, Christoph can intro founders to Hookipa Pharma's investors below.
Hookipa Pharma's investors · 2
Experience
- Curie.BioCSO & co-foundercurrent2022 — presentanywhere you want it to be
- Cancer Research UK (CRUK)Board Member of Cancer Research Horizons and Therapeutic Innovationcurrent2023 — presentLondon Area, United Kingdom
- Johns Hopkins UniversityAdjunct Associate Professorcurrent2005 — presentBaltimore, MD
- Johns Hopkins UniversityPrincipal Investigator1994 — 2005Baltimore, MD
- Thrive, An Exact Sciences CompanyConsultant, R&D strategy2021 — 2022Cambridge, MA
- Thrive, An Exact Sciences CompanyChief Innovation Officer & co-founder2019 — 2021Cambridge, MA and Baltimore, MD
- Advise Connect Inspire (ACI)CEO & founder2017 — 2022Greater Boston
- Third Rock VenturesPartner2018 — 2022Boston, MA
- Third Rock VenturesVenture Partner2016 — 2018Boston, MA
- Blueprint MedicinesExecutive Vice President2016 — 2021Cambridge, MA
- Blueprint MedicinesCSO & Chief Drug Hunter2012 — 2016Cambridge, MA
- MOMA TherapeuticsCSO & co-founder2020 — 2021Cambridge, MA
- Celsius TherapeuticsCSO, president & co-founder2018 — 2020Cambridge, MA
- Creative Destruction LabAssociate2018 — 2019Greater Toronto Area, Canada
- German Accelerator Life SciencesCEO2015 — 2019Cambridge, MA
- SanofiGlobal Head of Oncology Drug Discovery and Preclinical Development2008 — 2012Paris Area, France & Cambridge, MA
- NovartisUnit Head - Oncology Drug Discovery2005 — 2008Cambridge, MA
Skills & more
Entrepreneurship2Drug Discovery99Oncology12Life Sciences10Drug Development2Biotechnology
From Christoph's professional profile.
Deals · 1
Hookipa PharmaBoard seat
via Third Rock Ventures · filed Feb 2019
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Curie.Bio
Alexis Borisy
Operating Chairman at Curie.Bio
Andrew Warren
Senior Associate at Third Rock Ventures
Andy Garner
Senior Vice President at Curie.Bio
Devin Quinlan
Principal at MPM BioImpact
Lisa Huang
Senior Vice President at Curie.Bio
Michael Schlabach
Senior Vice President at Curie.Bio
Sue Wee
Senior Vice President at Curie.Bio
Zach Weinberg
CEO at Curie.Bio
Network5
Abbie Celniker
Investor at Third Rock Ventures
Alan Ezekowitz
Investor at Third Rock Ventures
Andrea van Elsas
Investor at Third Rock Ventures
Andrew Warren
Senior Associate at Third Rock Ventures
Barbara Weber
Venture Partner at Third Rock Ventures
Investors connected to Christoph in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Christoph Lengauer?
- Christoph Lengauer is the co-founder and Chief Scientific Officer of Curie.Bio, where he supports founders launching therapeutics companies. His work combines drug development expertise, services, and seed capital to help move companies from initial concept through Series A financing.
- Where does Christoph Lengauer work?
- Christoph Lengauer is CSO at Curie.Bio and Board director at Hookipa Pharma.
- What boards does Christoph Lengauer sit on?
- Christoph Lengauer holds tracked board seats at Hookipa Pharma.
- Where did Christoph Lengauer go to school?
- Christoph Lengauer studied at The Johns Hopkins University - Carey Business School (MBA, Medical Services Management); The Johns Hopkins University (Postdoc, Molecular Biology); Research Institute of Molecular Pathology (Postdoc, Molecular Biology).
Founder mafias
The Johns Hopkins University mafia58
Also came through, then founded or led a company.
Anne OsdoitMaster of Science (MS)Founded Moon Surgical +2Andrew LevyBachelor of Science (B.S.)Founded Apteligent +2Matt MichelsonB.S.Founded Evid Science +1Merrill AnovickB.A. with HonorsFounded Lynd Clinical +1Kanishk ParasharBSFounded Powder +1Ralph GooteeM.S. Applied MathematicsFounded TigerEye +1
+ 51 more
Creative Destruction Lab mafia31
Also came through, then founded or led a company.
Andrew NutterMentor - Space streamFounded Westwing +1Myra ArshadVenture - Matter StreamFounded Fluidic +1Christophe JurczakAssociateFounded PasqalMike CegelskiFellowFounded iBwaveAlice ReimerSite Lead, CDL-RockiesFounded the51Judy FairburnFellow - Energy TransitionFounded the51
+ 24 more
Third Rock Ventures mafia16
Also came through, then founded or led a company.
Reid HuberPartnerFounded MOMA Therapeutics +2Steve PaulVenture PartnerFounded Voyager Therapeutics, Inc. +1Alexis BorisyPartnerFounded Foundation Medicine +1Philip ReillyVenture PartnerFounded Luna Genetics +1Abbie CelnikerPartnerFounded Eleven BiotherapeuticsJeffrey FinerVenture PartnerFounded Septerna
+ 9 more
Cancerresearchuk mafia6
Also came through, then founded or led a company.
Olivia CavlanCancer Research Horizons Seed Fund Investment CommitteeFounded Alchemab TherapeuticsHemmel AmraniaClinical Research AssociateFounded DigistainEmmanouela PetsolariResearch ScientistFounded ACXElias KassellVolunteerFounded BrickwiseJohn CassidyResearch ScientistFounded Cambridge Cancer Genomics
Heidelberg University mafia5
Also came through, then founded or led a company.
Same school
Also attended The Johns Hopkins University - Carey Business School22
Tony WellsVenture Partner at Copper Sky CapitalFloyd H. GriffithManaging Partner at Little Bristol PartnersMelissa GuttmanPrincipal, Talent at JMI EquityVipul KellaInvestor at FortySix Venture CapitalAndrew MausManaging Director, North America at AI CapitalSaafir RabbAdvisor at Transform Capital Management
+ 16 more
Also attended The Johns Hopkins University261
Wes NicholsPartner at March Capital PartnersDemi ObayomiPrincipal at Sapphire VenturesJun JeonInvestor at Khosla VenturesNicole FraenkelInvestor at Khosla VenturesElena VibochManaging Director at General CatalystScott RubinVenture Partner at Lux Capital
+ 255 more
Also attended Heidelberg University44
Mojca SkoberneEntrepreneur in Residence at GV (Google Ventures)Keita Yazakiシニア・アソシエイト (Senior Associate) at CyberAgent CapitalLena ThiedeCo-Founder & General Partner at Planet A VenturesFabian HeilemannFounder & CEO at AENUJan MarchewskiPrincipal at Hitachi VenturesStella PaffenholzSenior Associate at Atlas Venture
+ 38 more
Shared employers
Also worked at Cancer Research UK (CRUK)24
Drew BurdonInvestor at LSP (Life Sciences Partners)Giovanni MariggiInvestor at MedicxiDominic SchmidtGeneral Partner at Advent Life SciencesJoanna SorokaInvestment Partner at Hitachi VenturesMilenko CicmilVenture Partner at Cure VenturesMartin TaylorPrincipal at F-Prime Capital Partners
+ 18 more
Also worked at Third Rock Ventures80
Lisa PurcellInvestor at Third Rock VenturesPaul MeloneInvestor at Third Rock VenturesKevin MunnellyInvestor at Third Rock VenturesAmanda ChanInvestor at Third Rock VenturesJigar RaythathaInvestor at Third Rock VenturesOlie LuchitskyInvestor at Third Rock Ventures
+ 74 more
Also worked at Blueprint Medicines6
Also worked at German Accelerator Life Sciences15
John Kojiro MoriwakaVenture Partner - Japan at Mendoza VenturesAmarit CharoenphanInvestor at NZVCHanna VillaInvestment Manager at Vorwerk VenturesKatharina SchildAssociate Manager at Danone Manifesto VentureKeshia Theobald-van GentPartner at BDev VenturesTina Di CiccoVenture Partner at Investible Climate Tech Fund
+ 9 more